348 related articles for article (PubMed ID: 25186232)
1. The Role of PICALM in Alzheimer's Disease.
Xu W; Tan L; Yu JT
Mol Neurobiol; 2015 Aug; 52(1):399-413. PubMed ID: 25186232
[TBL] [Abstract][Full Text] [Related]
2. PICALM and Alzheimer's Disease: An Update and Perspectives.
Ando K; Nagaraj S; Küçükali F; de Fisenne MA; Kosa AC; Doeraene E; Lopez Gutierrez L; Brion JP; Leroy K
Cells; 2022 Dec; 11(24):. PubMed ID: 36552756
[TBL] [Abstract][Full Text] [Related]
3. Role of phosphatidylinositol clathrin assembly lymphoid-myeloid leukemia (PICALM) in intracellular amyloid precursor protein (APP) processing and amyloid plaque pathogenesis.
Xiao Q; Gil SC; Yan P; Wang Y; Han S; Gonzales E; Perez R; Cirrito JR; Lee JM
J Biol Chem; 2012 Jun; 287(25):21279-89. PubMed ID: 22539346
[TBL] [Abstract][Full Text] [Related]
4. Central role for PICALM in amyloid-β blood-brain barrier transcytosis and clearance.
Zhao Z; Sagare AP; Ma Q; Halliday MR; Kong P; Kisler K; Winkler EA; Ramanathan A; Kanekiyo T; Bu G; Owens NC; Rege SV; Si G; Ahuja A; Zhu D; Miller CA; Schneider JA; Maeda M; Maeda T; Sugawara T; Ichida JK; Zlokovic BV
Nat Neurosci; 2015 Jul; 18(7):978-87. PubMed ID: 26005850
[TBL] [Abstract][Full Text] [Related]
5. Anti-malaria drug artesunate prevents development of amyloid-β pathology in mice by upregulating PICALM at the blood-brain barrier.
Kisler K; Sagare AP; Lazic D; Bazzi S; Lawson E; Hsu CJ; Wang Y; Ramanathan A; Nelson AR; Zhao Z; Zlokovic BV
Mol Neurodegener; 2023 Jan; 18(1):7. PubMed ID: 36707892
[TBL] [Abstract][Full Text] [Related]
6. The role of PTB domain containing adaptor proteins on PICALM-mediated APP endocytosis and localization.
Merthan L; Haller A; Thal DR; von Einem B; von Arnim CAF
Biochem J; 2019 Jul; 476(14):2093-2109. PubMed ID: 31300465
[TBL] [Abstract][Full Text] [Related]
7. Adaptor complex AP2/PICALM, through interaction with LC3, targets Alzheimer's APP-CTF for terminal degradation via autophagy.
Tian Y; Chang JC; Fan EY; Flajolet M; Greengard P
Proc Natl Acad Sci U S A; 2013 Oct; 110(42):17071-6. PubMed ID: 24067654
[TBL] [Abstract][Full Text] [Related]
8. Integrated late onset Alzheimer's disease (LOAD) susceptibility genes: Cholesterol metabolism and trafficking perspectives.
Dong HK; Gim JA; Yeo SH; Kim HS
Gene; 2017 Jan; 597():10-16. PubMed ID: 27773727
[TBL] [Abstract][Full Text] [Related]
9. Distribution and expression of picalm in Alzheimer disease.
Baig S; Joseph SA; Tayler H; Abraham R; Owen MJ; Williams J; Kehoe PG; Love S
J Neuropathol Exp Neurol; 2010 Oct; 69(10):1071-7. PubMed ID: 20838239
[TBL] [Abstract][Full Text] [Related]
10. The concerted amyloid-beta clearance of LRP1 and ABCB1/P-gp across the blood-brain barrier is linked by PICALM.
Storck SE; Hartz AMS; Bernard J; Wolf A; Kachlmeier A; Mahringer A; Weggen S; Pahnke J; Pietrzik CU
Brain Behav Immun; 2018 Oct; 73():21-33. PubMed ID: 30041013
[TBL] [Abstract][Full Text] [Related]
11. Clathrin adaptor CALM/PICALM is associated with neurofibrillary tangles and is cleaved in Alzheimer's brains.
Ando K; Brion JP; Stygelbout V; Suain V; Authelet M; Dedecker R; Chanut A; Lacor P; Lavaur J; Sazdovitch V; Rogaeva E; Potier MC; Duyckaerts C
Acta Neuropathol; 2013 Jun; 125(6):861-78. PubMed ID: 23589030
[TBL] [Abstract][Full Text] [Related]
12. Functional links between Aβ toxicity, endocytic trafficking, and Alzheimer's disease risk factors in yeast.
Treusch S; Hamamichi S; Goodman JL; Matlack KE; Chung CY; Baru V; Shulman JM; Parrado A; Bevis BJ; Valastyan JS; Han H; Lindhagen-Persson M; Reiman EM; Evans DA; Bennett DA; Olofsson A; DeJager PL; Tanzi RE; Caldwell KA; Caldwell GA; Lindquist S
Science; 2011 Dec; 334(6060):1241-5. PubMed ID: 22033521
[TBL] [Abstract][Full Text] [Related]
13. Implication of a genetic variant at PICALM in Alzheimer’s disease patients and centenarians.
Piaceri I; Bagnoli S; Lucenteforte E; Mancuso M; Tedde A; Siciliano G; Piacentini S; Bracco L; Sorbi S; Nacmias B
J Alzheimers Dis; 2011; 24(3):409-13. PubMed ID: 21297266
[TBL] [Abstract][Full Text] [Related]
14. The PICALM protein plays a key role in iron homeostasis and cell proliferation.
Scotland PB; Heath JL; Conway AE; Porter NB; Armstrong MB; Walker JA; Klebig ML; Lavau CP; Wechsler DS
PLoS One; 2012; 7(8):e44252. PubMed ID: 22952941
[TBL] [Abstract][Full Text] [Related]
15. Genetic association of PICALM polymorphisms with Alzheimer's disease in Han Chinese.
Yu JT; Song JH; Ma T; Zhang W; Yu NN; Xuan SY; Tan L
J Neurol Sci; 2011 Jan; 300(1-2):78-80. PubMed ID: 20951388
[TBL] [Abstract][Full Text] [Related]
16. PICALM rs3851179 Variant Confers Susceptibility to Alzheimer's Disease in Chinese Population.
Liu G; Xu Y; Jiang Y; Zhang L; Feng R; Jiang Q
Mol Neurobiol; 2017 Jul; 54(5):3131-3136. PubMed ID: 27048444
[TBL] [Abstract][Full Text] [Related]
17. Genetics of PICALM expression and Alzheimer's disease.
Parikh I; Fardo DW; Estus S
PLoS One; 2014; 9(3):e91242. PubMed ID: 24618820
[TBL] [Abstract][Full Text] [Related]
18. Meta-analysis of the Association between Alzheimer Disease and Variants in GAB2, PICALM, and SORL1.
Wang Z; Lei H; Zheng M; Li Y; Cui Y; Hao F
Mol Neurobiol; 2016 Nov; 53(9):6501-6510. PubMed ID: 26611835
[TBL] [Abstract][Full Text] [Related]
19. Genetic variation in PICALM and Alzheimer's disease risk in Han Chinese.
Jiang T; Yu JT; Tan MS; Wang HF; Wang YL; Zhu XC; Zhang W; Tan L
Neurobiol Aging; 2014 Apr; 35(4):934.e1-3. PubMed ID: 24095218
[TBL] [Abstract][Full Text] [Related]
20. Mass spectrometry quantification of PICALM and AP180 in human frontal cortex and neural retina.
Chen J; Pikuleva IA; Turko IV
Anal Biochem; 2013 Nov; 442(2):253-8. PubMed ID: 23954523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
